Poster Listing

Abstract

Leah Zajdlewicz

Decisions and prompts to screen for cervical, bowel, and breast cancer abs# 160

Shalmoli Bhattacharyya

Cancer-associated mesenchymal stem cells promote proliferation in chemo-radio-resistant cervical cancer cells abs# 161

Carina Chan

Identifying MET exon 14 skipping mutations in squamous cell lung cancer patients abs# 162

Zoe Clarke

Medical imaging simulated radiation therapy: Improving access to palliative radiation therapy in WNSWLHD abs# 163

Merran Findlay

Dashboards to deliver data-driven dietetics in the digital age: Translation of evidence-based nutrition guidelines into practice abs# 164

Subhash Gupta

Emerging therapeutic potential of Vardhamana Pippali Rasayana (Ayurvedic drug) in breast cancer abs# 165

Morgan Leske

Feasibility and preliminary efficacy of brief coaching calls in Healthy Living after Cancer Online: A randomized control trial abs# 166

Ashley Macleod

Investigating LGBTIQA+ Inclusion in Victorian Cancer Care: An incomplete picture abs# 167

Georgios Mavropalias

Implementation of eccentric exercise programs as therapy during cancer – A scoping review abs# 168

Geoffrey Yuet Mun Wong

Genomic profiling and biomarker discovery for predicting early intrahepatic recurrence following resection of colorectal liver metastases abs# 169

Navid Ahmadi

Perioperative and oncological outcomes of patients undergoing post-chemotherapy robotic-retroperitoneal lymph node dissection for management of primary testicular cancer abs# 170

Navid Ahmadi

Perioperative and oncological outcomes of patients undergoing primary robotic-RPLND for management of primary testicular cancer abs# 171

Reem ALHulais

Efficacy of celecoxib as an anticancer drug examined in the murine CT26 metastatic colorectal cancer model abs# 172

Dinuka Ariyarathna

Providing early access to geriatric oncology services in a regional cancer center – An evaluation of a newly established Nurse-Navigator led Geriatric Oncology Service Model and associated safety outcomes abs# 173

Ashish Banerjee

Dostarlimab for Primary Advanced or Recurrent (A/R) Endometrial Cancer (EC): Outcomes by Blinded Independent Central Review (BICR) of the RUBY trial abs# 174

Greta K Beale

Association between clinical outcomes and PSMA PET metrics in patients with metastatic prostate cancer abs# 175

Cassie Beaven

Immunotherapy in the setting of metastatic cutaneous squamous cell carcinoma – An OncoGeriatrics Perspective abs# 176

Cassie Beaven

An evaluation of time to treatment with adjuvant chemotherapy in high-risk early breast cancer patients in a regional setting abs# 177

Maria Bechelli

Improving access to trials: A rapid case ascertainment tool used to identify patients for recruitment abs# 178

Anish Bhattacharya

Role of 18F-FDG PET/CT for initial staging and treatment planning in pediatric sarcomas abs# 179

Jaimee Cacic

Prehabilitation improves nutritional and muscle parameters prior to esophago-gastric cancer surgery abs# 180

Cian Casey

Diagnostic efficacy of PET/CT percutaneous biopsy for suspected retroperitoneal sarcoma abs# 181

Felicity Casey

Real-world disease characteristics, testing patterns, and first-line treatment in RET fusion-positive advanced non-small cell lung cancer in Australia abs# 182

David Chen

Association between perioperative factors and DAH30 in oncology patients undergoing hepatobiliary resection: A retrospective cohort study abs# 183

Kar Ven Cavan Chow

Real-world outcomes and practices in extra-cranial, extra-gonadal germ cell tumor: A retrospective analysis of the Australian iTestis database abs# 184

Udari Colombage

The feasibility of pelvic floor muscle training to treat urinary incontinence in women with breast cancer: A telehealth intervention trial abs# 185

Jermaine Coward

AdvanTIG-105: Phase 1b dose-expansion study of ociperlimab + tislelizumab in patients with checkpoint inhibitor (CPI)-experienced advanced non-small cell lung cancer (NSCLC) abs# 186

Kate Crombie

Prehabilitation reduces postoperative surgical complications following esophago-gastric cancer surgery abs# 187

Ieta D'Costa

What is “actual racism” – Healthcare workers perceptions of race and racism abs# 188

Bianka D'souza

HER2 testing in advanced gastric cancer – Understanding and reducing variation in current practice to improve equity in patient outcomes abs# 189

Daphne Day

A phase 1b/2 study of OP-1250, an oral complete estrogen receptor (ER) antagonist (CERAN) and selective ER degrader (SERD) with palbociclib in patients (pts) with advanced or metastatic ER-positive, HER2-negative breast cancer (MBC) abs# 190

Daphne Day

A Phase 1 (Ph1) study of the OX40 agonist, BGB-A445, with or without tislelizumab, an anti-PD-1 monoclonal antibody (mAb), in patients with advanced solid tumors abs# 191

Georgia De'Ambrosis

A case of primary cutaneous marginal zone B-cell lymphoma on the cheek abs# 192

Christine Dijkstra

Solving Unknown Primary cancER (SUPER): A cohort study – Moving digital and adapting to challenges abs# 193

Hayley T Dillon

A combined exercise and sedentary behavior intervention preserves VO_2peak in adults undergoing allogeneic stem cell transplantation for hematological cancer abs# 194

Pei Ding

Real-world treatment and outcomes in resectable early-stage NSCLC: THASSOS-INTL Australia Analysis abs# 195

Bas Ebaid

Updated efficacy and safety of lenvatinib (LEN) + pembrolizumab (pembro) versus treatment of physician's choice (TPC) in patients (pts) with advanced endometrial cancer (aEC): Study 309/KEYNOTE-775 abs# 196

Linda Denehy

Exercise capacity prior to major cancer surgery: A cross-sectional observational study of the validity of the 6-minute walk and 30-s sit-to-stand tests abs# 197

Morgan J Farley

Myokine response to high intensity interval exercise and relationships with body composition and cardiorespiratory fitness in cancer survivors abs# 198

Stephanie Gasking

Treatment sequencing in the VISION study of tepotinib in patients with MET exon 14 (METex14) skipping NSCLC abs# 199

Lucy Gately

Exploring management of elderly patients with glioblastoma using data from 2 randomized trials (GEINO1401/EX-TEM) abs# 200

Priscilla Gates

Cancer-related cognitive impairment in patients with newly diagnosed aggressive lymphoma compared to healthy controls: An exploratory study abs# 201

Lilian Gauld

Colony stimulating factors to treat febrile neutropenia: What do we know and what should we be doing? abs# 202

Kazzem Gheybi

Scrutinizing the whole genome for potential genes to design an African exclusive prostate cancer germline panel abs# 203

Lee-att Green

Adjuvant immunotherapy for resected stage IIIB–IV melanoma; real world efficacy, toxicity, hospitalization rates, and steroid use abs# 204

Subhash Gupta

An Indian experience of safety and efficacy of trastuzumab in HER2+ve breast cancer patients in real world settings abs# 205

Omid Hamid

Significant durable response with fianlimab (anti-LAG-3) and cemiplimab (anti-PD-1) in advanced melanoma: Post-adjuvant PD-1 analysis abs# 206

Chad Han

An observational study of frailty, associated factors and outcomes in older adults with and without a cancer diagnosis in an acute medical unit abs# 207

Lauren Hanna

Energy expenditure in upper gastrointestinal cancer: A scoping review abs# 208

Andrew Haydon

COLUMBUS 7-Year Update: A randomized, open-label, Phase 3 trial of encorafenib (Enco) + binimetinib (Bini) versus vemurafenib (Vemu) or enco in patients (Pts) with BRAF V600-mutant melanoma abs# 209

Jolyn Hersch

Interventions to support patient decision making about taking part in health research: A systematic review abs# 210

Nicole Kiss

An untold story about living with low muscle mass and its impact throughout curative radiotherapy treatment for lung cancer abs# 211

Alexandra Knesl

Comparison of fluorouracil (5FU) versus capecitabine (Cape) as causative agents for admission in colorectal cancer (CRC) at the Princess Alexandra Hospital (PAH) abs# 212

Neil Lam

A comparison of carboplatin dosing between Cockcroft–Gault equation versus BSA-adjusted eGFRCKD-EPI equation abs# 213

Wing Kwan Winky Lo

Correlation of quantitative emphysema and lung nodules on low-dose CT (LDCT) in the Sydney Cohort of International Lung Screening Trial (ILST) abs# 214

Andrew van der Westhuizen

Complete and partial responses to azacitidine and carboplatin priming for ipilimumab and nivolumab re-challenge in patients with advanced melanoma who are resistant to immunotherapy abs# 215

Chunyan Ma

Lenvatinib versus sorafenib in the first-line treatment of patients with unresectable hepatocellular carcinoma (uHCC) and nonviral etiology: REFLECT post-hoc analysis abs# 216

Chunyan Ma

A phase 1b study of E7386, a CREB-binding protein/β-catenin interaction inhibitor, plus lenvatinib in patients with advanced hepatocellular carcinoma (HCC) abs# 217

Wing Tung Michelle Ma

Real-world survival outcomes of first line pembrolizumab plus chemotherapy for metastatic non-small cell lung cancer (NSCLC) in Australia abs# 218

Alina Mahmood

Assessing prevention of chemotherapy induced peripheral neuropathy with cryotherapy abs# 219

Jane McKenzie

Primary thoracic aorta angiosarcoma presenting with thromboembolism and progressive claudication despite anticoagulation abs# 220

Luke S McLean

Immune-checkpoint inhibitors for locally advanced and metastatic cutaneous squamous-cell carcinomas in a real-world Australian cohort abs# 221

Luke S McLean

Assessment of perineural spread in advanced cutaneous squamous cell carcinoma treated with immunotherapy abs# 222

Tara McSweeney

Checkpoint inhibitor rechallenge following significant toxicity – Can it be done successfully? abs# 223

Inderjit Mehmi

A Phase 1 study of fianlimab (anti-LAG-3) in combination with cemiplimab (anti-PD-1) in patients with advanced melanoma: Poor prognosis subgroup analysis abs# 224

Erin Moth

Experiences and decision-making perspectives of the informal carers of older adults with cancer abs# 225

Woo Jun Park

Demographic characteristics of culturally and linguistically diverse (CALD) cancer patients enrolled in early phase clinical trials in South Western Sydney abs# 226

Nick Pavlakis

Tepotinib + osimertinib in EGFR-mutant NSCLC with MET amplification following 1L osimertinib: INSIGHT 2 primary analysis abs# 227

Nick Pavlakis

Tepotinib + osimertinib in EGFR-mutant NSCLC with MET amplification following 1L osimertinib: INSIGHT 2 primary analysis abs# 228

Graham Pitson

Population-based glioblastoma treatment outcomes in Regional Victoria abs# 229

Lucy Porter

Retrospective audit of clinicopathological features and treatment in early-stage NSCLC – A real-world analysis of patient atezolizumab eligibility abs# 230

Benjamin N Rao

Carboplatin dosing – Impact of the eviQ ADDIKD Guidelines abs# 232

Danny Rischin

C-POST protocol update: A phase 3, randomized, double-blind study of adjuvant cemiplimab versus placebo postsurgery and radiation therapy in patients with high-risk cutaneous squamous cell carcinoma abs# 233

Bhavini Shah

Comparative analysis of survival outcomes and prognostic significance of brain metastasis in lung cancer patients across Gippsland abs# 234

Suman Bhasker

Patterns of care and outcomes in triple negative breast cancer: A retrospective study abs# 235

Tharani Sivakumaran

Evaluating the utility of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography/computer tomography in cancer of unknown primary abs# 236

Christopher Swain

Physical activity levels 30 days following allogeneic and autologous bone marrow transplant abs# 237

Sim Yee (Cindy) Tan

Cancer Nutrition and Exercise rehabilitation program (CaNE) for patients with advanced cancer at risk of cancer cachexia syndrome: Qualitative findings abs# 238

Elise Treleaven

Feasibility study to compare taste changes and dietary intake in patients with head and neck cancer according to genetically determined Taster Status abs# 239

Annalisa Varrasso

Real-world data from early access and patient access programs of avelumab first-line maintenance treatment in patients with locally advanced or metastatic urothelial carcinoma in Australia abs# 240

Annalisa Varrasso

Avelumab first-line (1L) maintenance for advanced urothelial carcinoma (aUC): Long-term outcomes from the JAVELIN Bladder 100 trial in older patients abs# 241

Annalisa Varrasso

Treatment patterns and criteria used to determine platinum eligibility in metastatic urothelial cancer: A real-world survey in Australia abs# 242

Shalini K Vinod

Implementation and evaluation of a geriatric-oncology model of care for older patients with lung cancer abs# 243

Luis Vitetta

The effect of a multi-species probiotic formulation to prevent chemotherapy induced diarrhea by rescuing gastrointestinal dysbiosis and mucositis: A pilot study abs# 244

Madeleine Washbourne

Incidence of febrile neutropenia and time to count recovery in patients with acute myeloid leukemia receiving pegylated G-CSF following High-Dose Cytarabine (HiDAC) Consolidation abs# 245

Adam P Whibley

Barriers and enablers to the uptake of referrals to allied health services by older people with cancer abs# 246

Colin Williams

A case of immunotherapy-induced epiglottitis abs# 247

Belinda Yeo

Ribociclib and endocrine therapy as adjuvant treatment in patients with HR+/HER2− early breast cancer: Primary results from the phase III NATALEE trial abs# 248

Wan Zhou

Comparative efficacy of immunotherapy or targeted therapy for patients with unresectable hepatocellular carcinoma: A pooled analysis of parametric survival curves abs# 249

Yvonne Zissiadis

Can coronary artery calcium score identified on thoracic radiotherapy planning CT scans be used and actioned to identify patients at high risk of cardiac events: A feasibility study in patients with cancer undergoing radiotherapy (RO-CARDIAC) abs# 250

Emma-Kate Carson

Telehealth cognitive behavior therapy for the management of sleep disturbance in women with early breast cancer receiving chemotherapy: A feasibility study abs# 251

Annalee L Cobden

A novel ecological momentary assessment app for the investigation of cognitive function variability in breast cancer survivors abs# 252

Udari N Colombage

Current physiotherapy practice around falls prevention in breast cancer care abs# 253

Virginia Dickson-Swift

Breast cancer screening motivations and behaviors for women aged ≥ 75 years abs# 254

Mr Thomas Fontes Andrade

Pre-diagnosis beta-blocker use and breast cancer survival outcomes: A systematic review abs# 255

Julia Freckelton

A 10 year experience of cardiac toxicity in patients receiving HER2 directed therapies at a tertiary Australian center abs# 256

Tamzin Hall

Changes in body weight during chemotherapy for early and metastatic breast cancer patients abs# 257

Jolyn Hersch

Women's views about current and future management of ductal carcinoma in situ (DCIS): A mixed-methods study abs# 258

Alison Hiong

The value of left ventricular ejection fraction assessment prior to adjuvant or neoadjuvant anthracycline chemotherapy in breast cancer abs# 259

Tamara Jones

Demographic and health characteristics associated with likelihood of uptake of digitally delivered cardiac rehabilitation for breast cancer survivors abs# 260

Emma Kemp

The impact of socioeconomic factors and social support on digital intervention engagement in people with breast cancer: A secondary data analysis abs# 261

Gillian Kruss

Robot-assisted education for metastatic breast care nurses: Innovative upskilling for an evolving role abs# 262

Prabhakar Ramachandran

A multi-institutional study on long-term incidence of contralateral second breast cancer following breast cancer radiation therapy – Preliminary results abs# 263

Gay M Refeld

A multi-method evaluation of a specialist breast nurse-led survivorship clinic abs# 264

Imogen IS Smith

Sacituzumab Govitecan: Optimization of supportive care measures abs# 265

Kellie Toohey

Clinical updates on the effects of high-intensity interval training (HIIT) exercise in people diagnosed with cancer. A systematic review and meta-analysis abs# 266

Michelle White

Exploring patient and clinician perceptions of pre-clinic patient-reported outcome measures (PROMs) and patient-reported experience measures (PREMs) in breast oncology outpatient clinics abs# 267

Victoria White

Surviving breast reconstruction: What information would help women? abs# 268

Robyn Brennen

Is telehealth pelvic floor muscle training feasible to treat incontinence after gynecological cancer? abs# 269

Robyn Brennen

Prevalence and incidence of pelvic floor disorders before and after hysterectomy for gynecological cancer abs# 270

Robyn Brennen

Associations between pelvic floor symptoms, physical activity, and health-related quality-of-life 3-months after hysterectomy for gynecological cancer abs# 271

Rachael H Dodd

Exploring women's experiences of receiving their cervical screening test results: A citizen science approach abs# 272

Cynthia Forbes

Associations among neighborhood characteristics, quality of life, and activity behaviors among gynecological cancer survivors in Nova Scotia, Canada abs# 273

Gabrielle C Gildea

Understanding what influences physical activity participation in women diagnosed with ovarian cancer: A qualitative study abs# 274

Lizzy Johnston

Association of protein intake with recurrence and survival following primary treatment of ovarian cancer abs# 275

Senara Kulatunga

Fear of cancer recurrence in older women with gynecological cancer at a regional cancer center abs# 276

Ben Smith

Can a self-guided online intervention for fear of cancer recurrence (iConquerFear) be feasibly, acceptably, and safely delivered to women affected by ovarian cancer? Results from a pilot randomized wait-list controlled trial abs# 277

Rosalind Spence

The inter-relationship between treatment-related adverse effects and exercise therapy in ovarian cancer survivors: Exploratory findings from the ECHO Trial abs# 278

Bree Stevens

Sharing lived experience to shape the future of gynecological cancer care abs# 279

Shalini K Vinod

Feasibility of measurement of quality indicators for the management of cervical cancer in New South Wales abs# 280

Gillian Blanchard

The growth and adaptation of a National Cancer Nurse Practitioner Network abs# 281

Jo Collins

Message from Matt: The power of the lived experience in educating health professionals abs# 282

Duncan Colyer

Early phase clinical trials information: Recommendations for equitable resources abs# 283

Germaine Tan

“Knowing my scope”: Development and evaluation of an allied health cancer rehabilitation training package (CaRe) abs# 284

Rachael H Dodd

Acceptability of an evidence-based booklet for HPV-related oropharyngeal squamous cell carcinoma patients and their partners abs# 285

Kath Dower

Co-designing educational resources for left breast cancer patients receiving deep inspiration breath hold radiation therapy abs# 286

Vicki Durston

SEAT AT THE TABLE: Elevating consumers to be more than storytellers abs# 287

Grace Gard

Reflecting the consumer voice in a patient education initiative for oncology patients; co-design in the development of a Personalized Care Plan for patients with rectal cancer abs# 288

Reegan K Knowles

Codesign of a web-based resource on cardiovascular disease risk in cancer for people affected by cancer and their health care providers abs# 289

Rebekah Laidsaar-Powell

Improving carer engagement in cancer care: Mixed methods evaluation of the eTRIO educational module among oncology health professionals abs# 290

Jane Lee

Attitudes and perceptions of Australian registered nurses on prescribing in cancer and palliative care abs# 291

Abbie Lockwood

Cancer support for people of refugee background (CSPRBB) abs# 292

Courtney Oar

Evaluation of a novel national blended learning program for cancer pharmacists abs# 293

Sandra Picken

Implementing the Optimal Care Pathway for Aboriginal and Torres Strait Islander people with cancer: A cross-sectional survey of health professionals practicing in Victoria, Australia abs# 294

Helena Rodi

What do Australian oncology health professionals know and practice regarding advance care planning? abs# 295

Joanne Shaw

Supporting cancer clinicians and researchers to provide culturally inclusive care to Aboriginal and Torres Strait Islander people: An e-learning resource abs# 296

Whiter Tang

The impact of compassionate care training for oncology pharmacists and technicians abs# 297

Megan Varlow

Climate change and cancer: Are we prepared? abs# 298

Nienke Dr Zomerdijk

Communication skills training for radiation therapists to improve First Nations cancer outcomes abs# 299

Taha Al-Mufti

Beyond the first fight: Secondary malignancies in patients from a private oncology practice and the potential role of obesity abs# 300

Maria Aslam

Prevalence of Australians exposed to potentially cardiotoxic cancer medicines: A population-based cohort study abs# 301

Phyu Sin Aye

National retrospective cohort study of safety and effectiveness of erlotinib and gefitinib in New Zealand for treating EGFR mutated lung cancer: Study protocol and results of the validation sub-study abs# 302

Hieu Chau

Impacts of the Victorian COVID-19 lockdowns on the number of cancer patients and stages at presentations to the Gippsland region abs# 303

Vicki Durston

Making metastatic breast cancer count: Barriers, enablers, and key recommendations identified through expert interviews and a national roundtable abs# 304

Lucy Gately

Linking data from a brain cancer clinical registry (BRAIN) with the state-based registry of Births Deaths Marriages: Improving the quality of clinical registry survival data abs# 305

Arana Hankijjakul

A review of COVID-19 infections in Australian adult cancer patients of a health service in Southeast Melbourne who received COVID-19 vaccinations abs# 306

Angela Lai

Real-world REarranged during Transfection [RET]-alteration testing and treatment patterns of patients with medullary and papillary thyroid cancer [MTC, PTC] in Australia abs# 307

Joann JL Lee

Outcomes of extensive-stage small-cell lung cancer (ES-SCLC) patients treated with platinum doublet and immunotherapy: A Western Australia retrospective review  abs# 308

Penny Mackenzie

Radiotherapy utilization rates for older patients with head and neck cancer in Qld: How do we compare? abs# 309

Bradley D Menz

Mass production of cancer-related disinformation through artificial intelligence: An alarming case study abs# 310

Edith Morais

Burden of adult recurrent respiratory papillomatosis: A systematic literature review  abs# 311

Huah Shin Ng

Patterns of mental health service utilization in people with cancer compared with people without cancer: The Australian National Study of Mental Health and Wellbeing analysis abs# 312

Marie Nguyen

Intrathyroid metastases: Epidemiology and recent advances abs# 313

Suzanne Poulgrain

Patterns of treatment and survival outcomes for people diagnosed with glioblastoma: A population-based study in Queensland abs# 314

Robert F Power

Modifiable risk factors for cancer among people with Lynch syndrome: An international, cross-sectional survey abs# 315

Euan Walpole

Benchmarking statewide cancer data: A comparison of breast and gynecological cancer care indicators between Victoria and Queensland abs# 316

Laura N Woodings

Prevalence of cancer in Victoria abs# 317

Taha Al-Mufti

Rapid diagnostic clinic: A new care model for suspected cancer patients in regional areas abs# 318

Susannah Ayre

A scoping review of group nutrition education and cooking programs for people affected by cancer abs# 320

Nicci Bartley

Developing a bereaved-centered model of bereavement care for an Australian healthcare setting abs# 321

Stephanie Best

Prioritizing implementation science research activities in cancer care abs# 322

Sean Black-Tiong

Working title: Exercise Medicine and Allied Health for cancer patients – Taking research into the real world abs# 323

Amy Bowman

Lung cancer exercise services in Australia: A point prevalence study abs# 324

Amy Bowman

Implementation of a Clinician-led Digital Health Workflow Review in prehabilitation  abs# 325

Jessica Bucholc

Exploring healthcare professionals and policymakers’ perspectives about the benefits of a nurse-led telephone cancer information support service abs# 326

Ryan Calabro

Unmet supportive cancer care needs in South Australia abs# 327

Belinda A Campbell

Lower radiotherapy utilization in patients with cutaneous T-cell lymphomas (CTCL) living in highly accessible areas abs# 328

Anna Chapman

Overcoming challenges in conducting systematic reviews in implementation science to advance cancer care abs# 329

Saji Chathanchirayil

Bridging the gap: Clinical and psycho-social profile of cancer patients attending a psycho-oncology clinic in rural Victoria abs# 330

Hieu Chau

A comparison of the toxicity profile of oral versus infusion 5-fluorouracil and the cost-benefit of DPD testing in a regional hospital setting abs# 331

Ashfaq Chauhan

Characterizing patient safety events among people from culturally and linguistically diverse backgrounds accessing cancer services in Australia: A retrospective medical record review study abs# 332

Natalie Chilko

Cancer surveillance in Australia: Minimum follow up recommendations abs# 333

Holly Chung

Qualitative perspectives of supportive care priorities from people with lung cancer: A bottom-up approach to value-based healthcare abs# 334

Holly Chung

Improving equity in cancer care: Clinical utility of a novel nursing checklist to identify social determinants of health in newly diagnosed cancer patients abs# 335

Jennifer Cohen

Developing an Education & Career Service for Adolescents and Young Adults with Cancer: A Participatory Intervention Mapping Approach abs# 336

Prue Cormie

People with cancer and health professional perceptions of willingness to pay for exercise services abs# 337

Annie R Curtis

Exploring dietitians’ practice and perspectives on the role of dietary patterns during cancer treatment: A qualitative study abs# 338

Diane Davey

Finding a better way: Defining a strategy for Allied Health across multiple providers in a regional cancer service abs# 339

Candice Donnelly

Can we measure what matters? Feasibility of clinically prioritized colorectal cancer quality indicators with a New South Wales population-based linked dataset abs# 340

Catherine Dunn

The medical oncology workforce perceptions of the current measurement and reporting of quality of care in clinical practice abs# 341

Catherine Dunn

A modified Delphi study to define and operationalize quality indicators from clinical registry data across sites for metastatic colorectal cancer abs# 342

Kim Edmunds

Value assessment for sustainable translation of exercise oncology interventions abs# 343

Kim Edmunds

Prostate Cancer Specialist Nursing Program: A social return on investment abs# 344

Nicola Fearn

SUppoRting PAtient-centred SurvivorShip (SURPASS) at St Vincent's Health Network: Adaptation of the ‘My Personal Plan’ Prostate Cancer Survivorship Care Plan for generic use abs# 345

Michelle Forgione

Medical oncologist perceptions and willingness to participate in voluntary assisted dying in South Australia abs# 346

Piers Gillett

Exploring the difference in travel distances for radiation therapy by tumor type in Victoria, Australia abs# 347

Louisa Gordon

Cost-effectiveness analysis of the navigate online treatment decision aid for men with prostate cancer and their partners abs# 348

Karla Gough

Inclusion and representative diversity in cancer psychological intervention trials abs# 349

Karla Gough

Patient-reported outcomes in routine clinical care: Understanding key steps in the roadmap to implementation abs# 350

Kate Graham

The prevalence of malnutrition and the risk of sarcopenia in immunotherapy treated patients abs# 351

Lisa Guccione

Does the solution address the problem? Using Implementation Science Frameworks to retrospectively assess the appropriateness and acceptability of an intervention to improve advance care planning in oncology settings abs# 352

Tilini Gunatillake

A CALL TO ACTION: “Equity is a culture” – Assessing perceptions of health (in)equity, the current landscape of health services for the development and the implementation of a Cancer Equity Framework abs# 353

Reema Harrison

Co-designing cancer services change with culturally and linguistically diverse communities: Learnings from the CanEngage Project abs# 354

Reema Harrison

Co-designing the CanSupport Program with carers of people with cancer in Australia abs# 355

Sharon He

Exploring Australian Healthcare professionals’ experiences and perceptions of management of older adults with cancer abs# 356

Nicole Heneka

Acceptability of a virtual prostate cancer survivorship care model in regional Australia: Findings from a multi-methods, single center feasibility pilot abs# 357

Martin Hong

Real world outcomes of patients with extensive stage small cell lung cancer – A multicenter Australian experience abs# 358

Amelia Hyatt

How often are patients recording their medical appointments and why? A national online mixed-methods survey in Australia abs# 359

Leah Savage

Survivorship needs of patients following radical treatment for cancer: Five-year results of the Cancer Survivorship Clinic (CSC) abs# 360

Donna O'Callaghan

Exercise and cancer pilot: Prescriptive exercise outside of the healthcare setting abs# 361

Angela Ives

Cancer Patient Experience Survey (CaPES) in Western Australia abs# 362

Angela Ives

Cancer Patient Experience Survey (CaPES) in WA abs# 363

Bishma Jayathilaka

Clinician perspectives on value and clinical utility of risk prediction for checkpoint inhibitor-induced immune-related adverse events (irAE) abs# 364

Ria Joseph

Systems-thinking to optimize dietary and exercise advice and referral practices for cancer survivors in Australia abs# 365

Bridget Josephs

A retrospective review of small cell lung cancer in a regional center in Victoria abs# 366

Sachin Joshi

Improving outcomes of patients with metastatic cancer – Audit of the Advance Cancer Multi-Disciplinary (ADMDT) Meeting in Gippsland abs# 367

Yoon-Jung Kang

Informing health system planning for biomarker-based treatment: Projections of prevalence for cancers with key pan-tumor biomarkers (dMMR, MSI, high TMB) in Australia to 2042 abs# 368

Mary A Kennedy

Standardizing care for exercise and nutrition in cancer in the South West (SCENIC-SW) abs# 369

Youngeun Koo

Quality of decision-making at oncology multidisciplinary team meetings: A structured observational study abs# 370

Judith Lacey

Developing strategies for safe and effective integration of Integrative Oncology programs and Wellbeing centers into comprehensive cancer care in Australia abs# 371

Julia Lai-Kwon

Barriers and facilitators to Electronic Patient-Reported Outcome (ePRO) Symptom Monitoring in Routine Oncology Care – A qualitative study guided by the Consolidated Framework for Implementation Research abs# 372

Cheng Ming Li

Understanding systems: Mapping Oncology Patient's journey at an Australian Academic Clinical Trials Unit (CTU) using the Functional Resonance Analysis Method (FRAM) abs# 373

Dan Luo

Cancer consumers perspectives on their involvement in health service improvement: A qualitative study abs# 374

Helen Hughes

The need for a national cancer-specific genomics framework abs# 376

David Mizrahi

The effect of exercise interventions on hospital length of stay and admissions during cancer treatment: A systematic review and meta-analysis abs# 377

Meng Tuck Mok

Prioritizing collection of CALD identifiers in cancer services abs# 378

Cassandra Moore

A review of lung cancer in Gippsland, Victoria abs# 379

Bronwyn Newman

Exploring healthcare engagement to improve patient safety in cancer care: A health systems analysis abs# 380

Drew Meehan

Cancer Council Australia's financial cost of cancer policy abs# 381

Kelly F Nunes-Zlotkowski

iCanBlend: Blended Psychological Therapy for the treatment of anxiety and depression in adult patients with an experience of cancer – A qualitative interview study abs# 383

Jasmine Ekaterina Persson

Systemic barriers to the provision of professionally led metastatic breast cancer support groups in Australia: Expert interviews with key informants abs# 384

Megan Prictor

A scoping review of Australian health service policies governing audio-visual recording abs# 385

Rebecca Purvis

Where do we stand? Professionals’ views on the determinants of clinical implementation of polygenic scores abs# 386

Md Mijanur Dr Rahman

Utilization of Medicare Chronic Disease Management item numbers for cancer survivors in Queensland, Australia abs# 387

Claire Rickard

Cancer multidisciplinary team meeting governance and quality: A network review and improvement priorities abs# 388

Kate E Roberts

Madeline's model: Embedding genomics into routine care to meet the lifelong needs of people with cancer and accelerate research abs# 389

Luna Rodriguez Grieve

Review of bereavement resources available at an Australian Healthcare Setting abs# 390

Lachlan Roth

A growing cohort: Investigating pharmacy service provision at discharge to outlying cancer inpatients abs# 391

Marissa Ryan

Telepharmacy service models for adult outpatients with cancer: A systematic review abs# 392

Marissa Ryan

Advancing the role of the pharmacy technician in cancer services: Authorizing and checking of compounded parenteral cancer medicines in Australia abs# 393

Sherine Sandhu

A pilot study to assess the feasibility and acceptability of collecting patient reported outcome and experience data from registry participants with primary epithelial ovarian cancer abs# 394

Tess Schenberg

A review of the Symptom Urgent Review Clinic at The Northern Hospital abs# 395

Manohan Sinnadurai

Avoiding preventable emergency presentations: Preliminary outcomes of the Oncology Nurse Practitioner-led Rapid Access Clinic Expansion (RACE) service at a tertiary regional cancer center abs# 396

Andrea Smith

Support group leaders’ perspectives on factors affecting implementation of professionally led groups for metastatic breast cancer: A qualitative study using Consolidated Framework for Implementation Research (CFIR-2.0) abs# 397

Jennifer Soon

The role of systemic therapies in current and emerging opportunities for de-escalation in melanoma: A scoping review protocol abs# 398

Koku Sisay Tamirat

Prostate cancer treatment variations in men from culturally and linguistically diverse backgrounds in Victoria, Australia abs# 399

Whiter Tang

The oncology day therapy pharmacists’ perception on workload and impact of electronic prescribing abs# 400

Natalie Taylor

Refining process mapping methods to pinpoint targets for implementation support: The “Ah-Ha” moment abs# 401

Shuang Liang

A study protocol for the P-OMICs-flow: Developing a novel precision medicine clinic to drive integration of research into routine healthcare abs# 402

Luc te Marvelde

Ongoing impacts of COVID-19 on new cancer diagnoses in Victoria, Australia abs# 403

Luc te Marvelde

COVID-19 impacts on lung cancer diagnosis, management, and timeliness in Victoria, Australia: A population based observational study abs# 404

Carla Thamm

Attributes, benefits, and effectiveness of comprehensive cancer centers: A scoping and systematic review of the international literature abs# 405

Elise Treleaven

Embedding person-centered oncology nutrition in practice: Implementation of electronic patient-led nutrition screening in the ambulatory cancer care setting abs# 406

Elise Treleaven

Early enteral feeding for patients receiving autologous stem cell transplant: When it is indicated can it be done? abs# 407

Haitham Tuffaha

Consensus recommendations for genetic testing in prostate cancer: A Delphi study abs# 408

Janette L Vardy

How do culturally and linguistically diverse cancer survivors use survivorship care plans? abs# 409

Megan Varlow

Putting liver on the agenda: A national roadmap for liver cancer control abs# 411

Laura N Woodings

Improving capture of stage at diagnosis by the Victorian Cancer Registry abs# 412

Jianrong Zhang

Time from diagnosis to treatment, risk factors, and prognostic impact: A cohort study for patients with lung tumors abs# 414

Adilah Amil

Patient Satisfaction Survey on telephone consultations implemented during the Covid-19 pandemic era abs# 415

Linda Saunders

Talking Blood Cancer Podcast – Connection through stories abs# 416

Kimberley Bury

COSA Pilot Project inspires Australian Teletrial Program abs# 417

Mary-Ann Carmichael

Role of radiation therapists in the provision of cancer survivorship care abs# 418

Duncan Colyer

The value of clinical trials seen through the lens of strategic plans abs# 419

Cassandra Dickens

Lessons learnt from implementation of an Oncology Nurse Practitioner-led Rapid Access Clinic Expansion (RACE) service at a tertiary regional cancer center abs# 420

Bridgitte Evans

Innovating to cross the divide: Establishing stereotactic radiosurgery in Central West NSW abs# 421

William Evans

Expanding clinical trials: Teletrial manager role and responsibilities abs# 422

Matthew Fuller

Palliative radiation therapy in WNSWLHD: Evaluating the clinical implications of an innovative and easier access model of care abs# 423

Lisa Gomes

Provision of integrated, melanoma-specific clinical psychology services to patients attending outpatient specialist clinics at the Melanoma Institute Australia abs# 424

Ellen Heywood

Cancer@Home: Model of care evaluation abs# 425

Caroline Lasry

Melanoma in Gippsland – Using data to drive service development abs# 426

Pippa Labuc

Restoring and embedding best practice cancer care in occupational therapy: A service evaluation abs# 427

Wei-Sen WL Lam

Retrospective audit of oncology inpatients admitted with immunotherapy related adverse events abs# 428

Melanie R Lovell

The Cancer Pain App: Translating evidence for effectiveness of non-pharmacological strategies to practice abs# 429

Narelle McPhee

Why do healthcare professionals discuss clinical trial participation with some rural cancer patients and not others? abs# 430

Louise Moodie

Willing and able: Learning from our patients to inspire the future of cancer-related malnutrition screening abs# 431

Alexandra Nolte

A model for increasing access to cancer support across Victoria abs# 432

Rayan Saleh Moussa

Breaking barriers, bridging cultures: Improving clinical trial access and participation in the Australian Arabic-speaking community abs# 433

Rayan Saleh Moussa

Improving the capture and reporting of adverse events in clinical trials of non-pharmacological interventions: A PaCCSC/CST initiative abs# 434

Kate Saw

Personalized cancer clinical trials navigator. Empowering cancer patients, driving cancer research abs# 435

Anthea Udovicich

Evaluating patient and healthcare professional experiences of oncology Occupational Therapy Education Sessions: A mixed methods study abs# 436

Matthew P Wallen

Student-led exercise physiology clinics in cancer care – A multi-purpose training opportunity abs# 437

Peta Wright

Supporting the wellbeing of cancer carers in a comprehensive cancer center abs# 438

Vanessa Yenson

Nothing about us without us: Partnering with consumers to promote clinical trials participation – How we tackled this with ConVICTioN abs# 439

Monique Bareham

From little things, big things grow abs# 440

Shae Beaton

Evaluation of group peer support at a Comprehensive Cancer Centre abs# 441

Shae S Beaton

Evaluation of an Oncology Massage Service at a Comprehensive Cancer Centre abs# 442

Katarzyna Bochynska

Enhancing access to supportive care services for people affected by cancer, how Cancer Council Liaisons make a difference – Clients’ perspective abs# 443

Katarzyna Bochynska

Enhancing access to supportive care services for people affected by cancer, how Cancer Council Liaisons make a difference – Healthcare professionals’ perspective abs# 444

Lisa Beatty

Testing the efficacy of a single-session online writing intervention on body image and distress in female cancer survivors: A randomized controlled trial abs# 445

Jenni Bruce

Answering the common questions: LGBTQI+ People and Cancer, a world-first information resource abs# 446

Raymond J Chan

The Supportive Care 2030 Movement: Unifying and futuristic ambitions for Supportive Cancer Care abs# 447

Udari N Colombage

Experiences and perspectives of pelvic floor disorders and treatment in women with breast cancer: A qualitative study abs# 448

Jack Dalla Via

Oncology healthcare professionals’ awareness and practice regarding the COSA position statement on exercise in cancer care: Understanding reach and barriers abs# 449

Domenica Disalvo

The effect of comprehensive geriatric assessment on care received, treatment completion, and outcomes for older adults receiving systemic anti-cancer treatment: A systematic review abs# 450

Domenica Disalvo

The effect of comprehensive geriatric assessment on treatment decisions and care received, and impact on cancer-related and geriatric assessment outcomes for older adults undergoing radiotherapy treatment: A systematic review abs# 451

Domenica Disalvo

The impact of comprehensive geriatric assessment on treatment decisions, care received, and postoperative outcomes in older adults with cancer undergoing surgery: A systematic review abs# 452

Genevieve Douglas

Exercise training improves persistent fatigue following allogeneic hematopoietic stem cell transplantation – A prospective pilot study abs# 453

Holly EL Evans

ExerciseGuide: A qualitative study of patients’ experiences of a web-based personalized exercise intervention for individuals with metastatic prostate cancer abs# 454

Miriam Ferres

Palliative Care Clinical Trials Research in non-Metropolitan settings – Opportunities for growth abs# 455

Cynthia Forbes

CANcer BEhavioural Nutrition and Exercise FeasIbility Trial: Early results and lessons learned abs# 456

Kate Furness

Perspectives of patients with advanced pancreatic cancer regarding a proposed intensive nutrition intervention: A qualitative investigation  abs# 457

Suzanne Grant

PRehabilitation and Supportive Care in women with Breast cancer (PROactive-B) abs# 458

Catherine Grigg

Effectiveness of diet-and-exercise interventions to facilitate dietary and physical activity behavior change in prostate cancer survivors: A systematic review abs# 459

Oliver Hodge

Photovoice, electronic Rapid Fitness Assessment (eRFA) and the This is Me (TiM) Tool for Enhanced Supportive Care Decisions: An implementation Feasibility Cross-sectional Study in a Regional Cancer Centre abs# 460

Kristin Hsu

SOCCER: Study of Oncological patients reCeiving COVID-19 vaccines whilst undergoing systemic thERapy for malignancy abs# 461

Samira Imran

Effective management of skin toxicities in cancer treatment: An Australian and New Zealand perspective abs# 462

Catherine Ashwell

The impact of implementing a 60-h methotrexate level on length of stay in patients with osteosarcoma in a tertiary hospital. abs# 463

Lizzy Johnston

Impact of caring for someone with cancer on the health behaviors of rural caregivers abs# 464

Tamara Jones

Representativeness of the ACSM Exercise Guidelines for cancer survivors: A review of the contributing evidence abs# 465

Hannah Jongebloed

Enabling health professionals to deliver smoking cessation care: A qualitative study on general practice nurses supporting people to quit smoking abs# 466

Emma Kemp

Access to digital health in cancer care: Exploring the perspectives of people living rurally and/or with socioeconomic disadvantage abs# 467

Deborah Kirk

Prevalence of distress and its associated factors among caregivers of people diagnosed with cancer: A cross-sectional study abs# 468

Deborah Kirk

Prevalence of distress, its associated factors, and referral to support services in people with cancer abs# 469

Vanessa Knibbs

Being away from home for cancer treatment: A qualitative study of patient experience and supportive care needs during radiotherapy abs# 470

Mei Krishnasamy

Design of patient-centered digital health interventions: Leveraging input from patients with brain tumors for unmet supportive care needs abs# 471

Meinir Krishnasamy

Consensus development of a contemporary framework for cancer supportive care abs# 472

Rebekah Laidsaar-Powell

Co-design of an online Cognitive Behavioural Therapy (iCBT) intervention for cancer carers with anxiety or depression: Development of CarersCanADAPT abs# 473

Erin Laing

Development of a novel NET-nutrition screening tool to identify patients requiring nutrition-related intervention and support abs# 474

Han Yang Lau

Do Australian national, state, and territory cancer plans include patient reported outcomes-related objectives and outcomes? abs# 475

Jane Lee

Improving lymphoedema care in Australia – Stakeholders perspective abs# 476

Grace Mackie

The role of support groups for people living with metastatic breast cancer in Australia abs# 477

Rebecca McLean

Connecting consumers with connected care – Teletrials abs# 478

Claire Munsie

“My Life Now is… ”; Benefits of group-based exercise in adolescent and young adult cancer survivors in their own words abs# 479

Andrew Murnane

Fitness, body composition, and HRQoL in long-term survivors of adolescent and young adult (AYA) cancers abs# 480

Sandra Picken

Defining and implementing a standardized monitoring and reporting process to monitor and communicate alignment with the Optimal Care Pathways abs# 481

Rebecca Venchiarutti

Survivorship needs in patients with head and neck cancer in regional/remote areas: A qualitative study abs# 482

Ursula M Sansom-Daly

Do young people who survive cancer, identify as “survivors”? Prevalence and predictors of cancer-related identities among adolescents and young adults following cancer abs# 483

Linda Saunders

Thriving at any age, any stage, anywhere: Redefining survivorship support for the blood cancer community abs# 484

Catherine Seet-Lee

Does exercise change blood flow to tumors? Acute aerobic exercise effects on liver metastases blood flow: A case series abs# 485

Anna C Singleton

Variations in supportive care needs between patients with breast, colorectal, lung, ovarian, and prostate cancer in Australia: Across-sectional survey abs# 486

Malini Sivasaththivel

PD-1 inhibitor induced skin reactions abs# 487

Belinda Steer

Is malnutrition risk screening enough to identify patients in need of nutrition interventions? abs# 488

Christopher B Steer

Use of electronic geriatric assessment to facilitate the enhanced supportive care of older adults at an Australian Regional Cancer Centre abs# 489

Lara Stoll

Development and implementation of a Radiation Therapy Talking Book (eBook) for First Nations cancer patients abs# 490

Megumi Uchida

Terminal delirium related distress is associated with bereaved prolonged grief disorder abs# 491

Rebecca L Venchiarutti

Clinical and research priorities for the management of multimorbidity in cancer survivors in Australia: A Delphi study abs# 492

Kyra Webb

A systematic review and meta-analysis of caregiver fear of cancer recurrence: Levels, measures, and associations abs# 493

Kyra Webb

The CARE-FCR: Development and validation of a caregiver-specific measure of fear of cancer recurrence and progression abs# 494

Hattie Wright

Eating behavior and dietary characteristics of long-term prostate cancer survivors abs# 496

Vanessa M Yenson

Defining research priorities and needs in cancer symptoms for adults diagnosed with cancer: An Australian/New Zealand modified Delphi study abs# 497

Eva Yuen

Examining the role of social support to manage wellbeing among culturally and linguistically diverse cancer caregivers abs# 498

Eva Yuen

The mediating role of psychological help-seeking stigma on depression, anxiety, and stress in people with cancer from culturally and linguistically diverse communities abs# 499

Eva YN Yuen

A qualitative examination of the information needs of caregivers of people with cancer from culturally and linguistically diverse backgrounds abs# 500

Leah Zajdlewicz

Empowering rural cancer survivors: Identifying information needs and strategies to meet those needs abs# 501

Eva M Zopf

Counteracting mental health issues in men with prostate cancer through exercise – A randomized controlled trial abs# 502

Ana Baramidze

A Phase 3 trial of fianlimab (anti-LAG-3) plus cemiplimab (anti-PD-1) versus pembrolizumab in patients with previously untreated unresectable locally advanced or metastatic melanoma abs# 503

Victoria Choi

Pilot randomized sham-controlled trial of electroacupuncture at onset of chemotherapy-induced peripheral neuropathy (CIPN) in patients with breast cancer abs# 504

Catherine Dunn

Trial in progress: BETTER-TRACC – BEnchmarking and Tracking TrEatment and Response in Advanced Colon Cancer abs# 505

Priscilla Gates

Web-based cognitive rehabilitation intervention for cancer-related cognitive impairment following chemotherapy for aggressive lymphoma: A randomized pilot trial abs# 506

Mandy M Goodyear

Investigating the use of two Delfin Moisture Meter measuring tools – MMDC (Moisture Meter D Compact) and MMEpiD (Moisture Meter Epidermis D) – for accurate assessment of Post-operative Breast Oedema abs# 507

Subhash Gupta

“Clinical validation of synergistic effect of Vardhamana Pippali Rasayana along with conventional treatment after unraveling its complex molecular mechanism of action in breast cancer: From experimental model to clinical trial” abs# 508

Lauren Hanna

Supplemental Jejunal Feeding to improve quality of life in advanced pancreatic cancer: Study protocol for a randomized controlled trial abs# 509

Erin Laing

Investigating the nutritional status, outcomes, and needs of adolescent and young adults (AYA) following a cancer diagnosis: Protocol for a mixed-methods study abs# 510

Andrew van der Westhuizen

Phase II study of azacitidine and carboplatin priming for Ipilimumab and Nivolumab re-challenge in patients with advanced melanoma who are resistant to immunotherapy: PRIME005 abs# 511

Timothy J. Panella

A Phase 3 trial comparing fianlimab (anti-LAG-3) plus cemiplimab (anti-PD-1) to pembrolizumab in patients with completely resected high-risk melanoma abs# 512

Janine Porter-Steele

Protocol of a feasibility randomized controlled trial of an intervention to enhance recovery from breast cancer treatment abs# 513

Rayan Saleh Moussa

Bright light therapy for the prevention of delirium in hospitalized adults with advanced cancer: A pilot feasibility trial abs# 514

Tharani Sivakumaran

FAPI-CUP – A prospective cohort study of patients with Cancer of Unknown Primary (CUP) to evaluate a novel radiotracer, fibroblast activated protein (FAPI) targeting cancer-associated fibroblasts to improve primary site detection abs# 515

Amelia K Smit

The Sun Wise Study: A randomized controlled trial of a personalized skin cancer prevention strategy among people with a history of skin cancer abs# 516

Annalisa Varrasso

SPADE: Design of a real-world observational study of avelumab first-line maintenance (1LM) in advanced urothelial carcinoma (UC) in the Asia-Pacific (APAC) region abs# 517